ERBB2 and breast carcinoma: Thus, in this review, we introduce, in detail, the drug action mode, indication, administration, efficacy, strengths, and challenges of various HER2-positive breast cancer targeted therapy drugs, involving drugs approved and in clinical trials, in order to summarize the current targeted therapy drugs and therapeutic regimen for HER2-positive breast cancer, and provide references for more precise treatment strategy.